Cage Bio develops novel products for dermatology, inflammation, and immunology.
Cage Bio's investors include Propel(X).
Cage Bio is headquartered in San Carlos, United States.
Cage Bio develops novel products for dermatology, inflammation, and immunology.
Cage Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cage Bio — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/cage-bio. Accessed September 30, 2026.
VCBacked. (2025). Cage Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cage-bio
{{cite web |title=Cage Bio — Funding & Investors |url=https://www.vcbacked.co/company/cage-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated